Infectious disease diagnosis is basically a diagnostic procedure that is done for detecting the presence of foreign antigens / organisms with the help of various diagnostic tools that is executed with the help of skilled technicians or physicians. The sample of blood, urine, mucus, or other body fluids are analyzed to provide information about the causative organism by the use of various diagnosis procedure and instruments.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589
Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics
According to the new market research report “Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027”, published by MarketsandMarkets™. [294 Pages Report] The global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.
The reagents, kits, and consumables segment accounted for the largest share of the infectious disease diagnostics market, by product & service segment, in 2021
Based on product & service, the infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. In 2021, the reagents, kits, and consumables segment accounted for the largest share of this market. The requirement of reagents, kits, and consumables in large numbers compared to instruments is the main factor contributing to the large share of this segment. Unlike instruments, reagents, kits, and consumables segment requires repeat purchases, which results in its stable demand among end users.
Browse Complete Report @ https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
POC testing segment to register the highest CAGR during the forecast period
Based on the type of testing, the infectious disease diagnostics market has been segmented into laboratory testing and POC testing. In 2021, the POC testing segment accounted for the highest CAGR. This can be attributed to the need to closely monitor patient conditions and advantages such as faster diagnosis.
The COVID-19 segment accounted for the largest share of the infectious disease diagnostics market, by disease type segment, in 2021
Based on disease type, the infectious disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis, CT, NG, HPV, Tuberculosis, influenza, syphilis, mosquito-borne diseases and other infectious diseases. In 2021, the COVID-19 disease type segment accounted for the largest share of this market due to factors such as the increasing number of cases and the availability of many COVID-19 diagnostic tests.
The diagnostic laboratories segment accounted for the largest share of the infectious disease diagnostics market, by end user segment, in 2021
Based on end user, the infectious disease diagnostics market has been segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. In 2021, diagnostic laboratories accounted for the largest share of the infectious disease diagnostics market. Diagnostic laboratories command the major share of the infectious disease diagnostics market owing to increased test volume of infectious diseases and strengthening healthcare infrastructure for efficient disease diagnosis and treatment.
North America is the largest regional market for infectious disease diagnostics market
The infectious disease diagnostics market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the infectious disease diagnostics market. The large share of this region can be attributed to the highly developed healthcare system in the US and Canada, the presence of many leading national clinical laboratories, and the easy accessibility to technologically advanced instruments.
The major players operating in this market are Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Siemens Healthineers AG (Germany), Danaher Corporation (US), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Hologic, Inc. (US), QIAGEN N.V. (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics Holdings plc (US), Quidel Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems (US), Seegene, Inc. (South Korea), Co-Diagnostics (US), ELITechGroup (France), Epitope Diagnostics (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International (US), Vela Diagnostics (Singapore) and Uniogen Oy (Finland).
This report categorizes the infectious disease diagnostics market into the following segments and subsegments:
- Reagents, Kits, and Consumables
- Software & Services
By Type of Testing
- Laboratory Testing
- POC Testing
- Clinical Microbiology
- DNA Sequencing & NGS
- DNA Microarray
- Other technologies
By Disease Type
- Hospital-acquired Infections
- Chlamydia Trachomatis
- Neisseria Gonorrhea
- Mosquito-borne Diseases
- Other Infectious Diseases
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic Research Institutes
- Other End Users
- North America
- Rest of Europe (RoE)
- Asia Pacific
- Rest of Asia Pacific (RoAPAC)
- Latin America
- Middle East & Africa
Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the infectious disease diagnostics market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?